05/31/2024 1:38 PM | BISCHOFBERGER NORBERT W (Reporting) Vir Biotechnology (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/31/2024 1:40 PM | BISCHOFBERGER NORBERT W (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 1:42 PM | Farid Ramy (Reporting) Vir Biotechnology (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/31/2024 1:43 PM | Farid Ramy (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 3:06 PM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 3:05 PM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/19/2024 7:40 AM | Vir Biotechnology (Filer)
| Form ARS | |
|
04/19/2024 7:32 AM | Vir Biotechnology (Filer)
| Form DEF 14A | |
04/19/2024 7:35 AM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/18/2024 7:44 AM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2024 3:14 PM | De Backer Marianne (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 7:58 PM | HANLY ANN M. (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:18 AM | Lee Sung (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:32 PM | Lee Sung (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:32 PM | De Backer Marianne (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:34 PM | HANLY ANN M. (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:30 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:31 PM | Pang Phillip (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 3:32 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 8:02 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 3:35 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 5:56 PM | Pang Phillip (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 6:59 AM | STATE STREET CORP (Filed by) Vir Biotechnology (Subject)
| Form SC 13G | |
01/23/2024 3:14 PM | BlackRock Inc. (Filed by) Vir Biotechnology (Subject)
| Form SC 13G/A | |
01/03/2024 1:47 PM | Pang Phillip (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 3:33 PM | Vir Biotechnology (Filer)
| Form S-3ASR | |
11/03/2023 3:37 PM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/20/2023 1:15 PM | MORE ROBERT J (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 1:14 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2023 7:01 AM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2023 5:02 AM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 2:54 PM | SCANGOS GEORGE A (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 3:14 PM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/20/2023 7:04 AM | Vir Biotechnology (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/05/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:15 PM | SATO VICKI L (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 4:17 PM | SATO VICKI L (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/29/2023 4:01 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Claim your free seat by clicking here now. |
06/15/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 3:30 PM | Pang Phillip (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2023 8:00 PM | SVF Endurance Ltd (0001782338) (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 4:58 PM | Horn Howard (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2023 11:19 AM | Ramasastry Saira (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 11:20 AM | Rice Steven J. (Reporting) Vir Biotechnology (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/01/2023 3:25 PM | Ramasastry Saira (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023 3:27 PM | Rice Steven J. (Reporting) Vir Biotechnology (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |